| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Dec―02 |
Novel mRNA vaccines targeting epitope-rich regions of avian coronavirus enhance immunogenic efficacy |
Miao Shen, Jielin Yao, Shengkui Xu, Bowen Zhang, Xiang Li, Wenke Ruan |
| 2 |
[GO] |
2025―Aug―05 |
Development of in vitro plaque-based assay for assessment of antibody-dependent enhancement in SARS-CoV-2 infection |
Pimploy Rattanaamnuaychai, Surachet Benjathummarak, Pannamthip Pitaksajjakul, Pongrama Ramasoota, Yong Poovorawan, Hiroto Mizushima, Masashi Tatsumi, Yoshiharu Matsuura, Atsushi Yamanaka |
| 3 |
[GO] |
2025―Jul―18 |
Comparative assessment of a multiplex micro-chip immunoassay, VaxArray, and meso scale discovery assay for serotype-specific coronavirus IgG quantitation |
Ashvi Sanjay Jain, Thorsten Verch, Gowrisankar Rajam, Ying Homan |
| 4 |
[GO] |
2025―May―28 |
Multiplex ACE2-RBD binding inhibition assay: An integrated tool for assessing neutralizing antibodies to SARS-CoV-2 variants and protection against breakthrough infections |
Emma Bloch, Laura Garcia, Françoise Donnadieu, Jason Rosado, Delphine Planas, Timothée Bruel, Laurent Hocqueloux, Thierry Prazuck, Olivier Schwartz, Laura Tondeur, Laurie Pinaud, Arnaud Fontanet, Stéphane Pelleau, Michael White |
| 5 |
[GO] |
2025―Jan―04 |
Evaluation of self-collected dried blood spots for detection of SARS-CoV-2 nucleocapsid antibodies shows low sensitivity |
Thomas Egger, Tamara Dörr, Reto Thoma, Susanne Nigg, Lorenz Risch, Alessio Cremonesi, Pietro Vernazza, Philipp Kohler, Christian R. Kahlert |
| 6 |
[GO] |
2024―May―31 |
Establishment of human post-vaccination SARS-CoV-2 standard reference sera |
Jinhua Xiang, Louis Katz, Patricia L. Winokur, Ashok Chaudhary, Barbara Digmann, Rebecca Bradford, Sujatha Rashid, Sudakshina Ghosh, Angela Robertson, Joseph Menetski, Miao Xu, Peng Gao, Catherine Z. Chen, Taylor Lee, Brittany Poelaert, Richard T. Eastman, Matthew D. Hall, Jack T. Stapleton |
| 7 |
[GO] |
2024―May―31 |
Development of an enzyme-linked immunosorbent assay using a monoclonal antibody to a dominant epitope in non-structural protein 4 of porcine reproductive and respiratory syndrome virus |
Chaolun Fu, Qingyuan Shao, Lei Zhang, Xinyu Cui, Ting Chen, Chang Tian, Fenglu Qian, Xuefei Chu, Yingchao Li, Pingping Yang, Yanmeng Hou, Yihong Xiao |
| 8 |
[GO] |
2024―May―15 |
Assessment of an in-house IgG ELISA targeting SARS-CoV-2 RBD: Applications in infected and vaccinated individuals |
Hernan H.M. da Costa, Valeria Oliveira Silva, Gustavo Carvalho Amorim, Marcia Grando Guereschi, Luciana Marciano Sergio, Carlos Henrique Rodrigues Gomes, Marisa A. Hong, Elaine L. de Oliveira, Luis F.M. Brígido, José A.L. Lindoso, Carlos R. Prudencio |
| 9 |
[GO] |
2024―May―03 |
SARS-CoV-2 spike protein expression as an identification in quality control testing for Adenovector based COVID-19 vaccine |
Harit Kasana, Ajay Kumar Ade, Jaipal Meena, Archana Sayal, Faraz Sheikh, Anupkumar R. Anvikar, Harish Chander |
| 10 |
[GO] |
2024―Apr―07 |
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: Comment |
Hinpetch Daungsupawong, Viroj Wiwanitkit |
| 11 |
[GO] |
2024―Mar―14 |
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study |
Nejla Stambouli, Khadija Bahrini, Chihebeddine Romdhani, Aicha Rebai, Sana Boughariou, Mohamed Zakraoui, Bilel Arfaoui, Sameh Seyli, Yasmine Boukhalfa, Riadh Battikh, Mohamed Ben Moussa, Iheb Labben, Mustpha Ferjani, Hedi Gharssallah |
| 12 |
[GO] |
2023―Nov―30 |
Development of automated microfluidic immunoassays for the detection of SARS-CoV-2 antibodies and antigen |
Linwood Johnson, Maggie L. Bartlett, Francisco Ramirez, Christopher D. Heger, Darci R. Smith |
| 13 |
[GO] |
2023―Sep―11 |
Obtaining a high titer of polyclonal antibodies from rats to the SARS-CoV-2 nucleocapsid protein and its N- and C-terminal domains for diagnostic test development |
Michelle Teixeira de Almeida, Ana Paula Barbosa, Camila Gasque Bomfim, Aline Biazola Visnardi, Tania Churasacari Vinces, Alexandre Ceroni, Edison Luiz Durigon, Cristiane Rodrigues Guzzo |
| 14 |
[GO] |
2023―Sep―06 |
Optimisation of SARS-CoV-2 peptide stimulation and measurement of cytokine output by intracellular flow cytometry and bio-Plex analysis |
Jemma Victoria Taylor, Emma Louise Callery, Anthony Rowbottom |
| 15 |
[GO] |
2023―Aug―10 |
Performance comparison of three commercial tests for the detection of SARS-CoV-2 antibodies in a common set of pediatric samples |
Sophonie J. Oyeniran, Huanyu Wang, Kathy Everhart, Kathy Mack, Kevin Harvey, Amy L. Leber |
| 16 |
[GO] |
2023―Jun―29 |
Effect of wash media type during PBMC isolation on downstream characterization of SARS-CoV-2-specific T cells |
Zion Congrave-Wilson, Minjun Kim, Aaron Sutherland, Jaycee Jumarang, Yesun Lee, Jennifer Del Valle, Wesley A. Cheng, Ricardo Da Silva Antunes, Pia S. Pannaraj |
| 17 |
[GO] |
2023―May―19 |
Anti-N SARS-CoV-2 assays for evaluation of natural viral infection |
Aurelia Gaeta, Antonio Angeloni, Anna Napoli, Beatrice Pucci, Lilia Cinti, Piergiorgio Roberto, Flavia Colaiacovo, Elena Berardelli, Antonella Farina, Guido Antonelli, Emanuela Anastasi |
| 18 |
[GO] |
2023―May―16 |
Validation of dried blood spot sampling for detecting SARS-CoV-2 antibodies and total immunoglobulins in a large cohort of asymptomatic young adults |
P. Ferentinos, D. Snape, F. Koivula, S. Faustini, A. Nicholson-little, M. Stacey, R. Gifford, I. Parsons, L. Lamb, J. Greeves, J. O'Hara, A.F. Cunningham, D. Woods, A. Richter, M.K. O'Shea |
| 19 |
[GO] |
2023―May―11 |
Development and validity assessment of ELISA test with recombinant chimeric protein of SARS-CoV-2 |
Zoraida Fernandez, Rudielle de Arruda Rodrigues, Jaire Marinho Torres, Gláucia Barbosa Marcon, Eduardo de Castro Ferreira, Vanessa Felipe de Souza, Elaine Fernandes Baez Sarti, Guilherme Ferminao Bertolli, Daniel Araujo, Luiz Henrique Ferraz Demarchi, Gislene Lichs, Marina Umaki Zardin, Crhistinne Cavalheiro Maymone Gonçalves, Valter Cuenca, Alexsandra Favacho, Jislaine Guilhermino, Lenita Ramires dos Santos, Flábio Ribeiro de Araujo, Marcio Roberto Silva |
| 20 |
[GO] |
2023―May―11 |
Clinical evaluation of commercial SARS-CoV-2 serological assays in a malaria endemic setting |
Djeneba Dabitao, Kathryn Shaw-Saliba, Drissa S. Konate, Helene C. Highbarger, Perrine Lallemand, Ibrahim Sanogo, Tauseef Rehman, Mamadou Wague, Nadie Coulibaly, Bourahima Kone, Bocar Baya, Seidina A.S. Diakite, Seydou Samake, Esther Akpa, Moctar Tounkara, Sylvain Laverdure, Seydou Doumbia, H. Clifford Lane, Mahamadou Diakite, Robin L. Dewar |
| 21 |
[GO] |
2023―Apr―12 |
Comparative evaluation of Luminex based assays for detection of SARS-CoV-2 antibodies in a transplantation laboratory |
A. Cox, M. Stevens, D. Kallon, A. Gupta, E. White |
| 22 |
[GO] |
2023―Mar―11 |
A FluoroSpot B assay for the detection of IgA and IgG SARS-CoV-2 spike-specific memory B cells: Optimization and qualification for use in COVID-19 vaccine trials |
Hélène Bisceglia, Julie Barrier, Joseline Ruiz, Anke Pagnon |
| 23 |
[GO] |
2023―Feb―25 |
An optimized flow cytometry protocol for simultaneous detection of T cell activation induced markers and intracellular cytokines: Application to SARS-CoV2 immune individuals |
Tiziana Altosole, Gianluca Rotta, Chiara R.M. Uras, Scott J. Bornheimer, Daniela Fenoglio |
| 24 |
[GO] |
2023―Feb―10 |
Methodological approaches to optimize multiplex oral fluid SARS-CoV-2 IgG assay performance and correlation with serologic and neutralizing antibody responses |
Nora Pisanic, Annukka A.R. Antar, Kate L. Kruczynski, Magdielis Gregory Rivera, Santosh Dhakal, Kristoffer Spicer, Pranay R. Randad, Andrew Pekosz, Sabra L. Klein, Michael J. Betenbaugh, Barbara Detrick, William Clarke, David L. Thomas, Yukari C. Manabe, Christopher D. Heaney |
| 25 |
[GO] |
2023―Feb―01 |
Elevation of truncated (48 kDa) form of unconventional myosin 1C in blood serum correlates with severe Covid-19 |
Yuriy Kit, Marina Starykovych, Nazar Manko, Andrii Orfin, Tamila Alexanyan, Lydmyla Bozhko, Tetiana Turchyna, Oleg Kit, Roopesh Krishnankutty, Anjana Anand, Andrey Sibirny, Serhiy Souchelnytskyi, Rostyslav Stoika |
| 26 |
[GO] |
2022―Dec―31 |
Dried blood spots are a valid alternative to venipuncture for COVID-19 antibody testing |
Matthew D. Sims, Robert H. Podolsky, Karen L. Childers, Barbara Higgins, Jillian Trueman, Ramin Homayouni, Daniel R. Voss, Natalie Berkiw-Scenna, Hans Keil, Richard H. Kennedy, Gabriel N. Maine |
| 27 |
[GO] |
2022―Oct―25 |
Intranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice |
Lachlan P. Deimel, Xin Liu, Javier Gilbert-Jaramillo, Sai Liu, William S. James, Quentin J. Sattentau |
| 28 |
[GO] |
2022―Oct―04 |
Novel bridge multi-species ELISA for detection of SARS-CoV-2 antibodies |
Aldana Trabucchi, Silvina Sonia Bombicino, Juan Ignacio Marfía, Adriana Victoria Sabljic, Rubén Francisco Iacono, Ignacio Smith, Gregorio Juan Mc Callum, Alexandra Marisa Targovnik, Federico Javier Wolman, Matías Fingermann, Leonardo Gabriel Alonso, María Victoria Miranda, Silvina Noemí Valdez |
| 29 |
[GO] |
2022―Sep―07 |
COVID-19 in patients with B cell immune deficiency |
Paschalis Vergidis, Emily R. Levy, Elizabeth H. Ristagno, Vivek N. Iyer, John C. O'Horo, Avni Y. Joshi |
| 30 |
[GO] |
2022―Aug―30 |
Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination |
Grace Kenny, Riya Negi, Sophie O'Reilly, Alejandro Garcia-Leon, Dana Alalwan, Colette Marie Gaillard, Gurvin Saini, Rosana Inzitari, Eoin R. Feeney, Obada Yousif, Aoife Cotter, Eoghan de Barra, Corinna Sadlier, Fiona Crispie, Peter Doran, Virginie Gautier, Patrick W.G. Mallon |
| 31 |
[GO] |
2022―Aug―17 |
Digital RT-PCR Chip method for detection of SARS-CoV-2 virus |
Laura Dioni, Annarosa Orlandi, Sara Uceda Renteria, Chiara Favero, Giulia Solazzo, Massimo Oggioni, Valentina Bollati |
| 32 |
[GO] |
2022―Jun―02 |
Evaluation of antibody titer kinetics and SARS-CoV-2 infections in a large cohort of healthcare professionals ten months after administration of the BNT162b2 vaccine |
Davide Ferrari, Alessandro Ambrosi, Chiara Di Resta, Rossella Tomaiuolo, Massimo Locatelli, Giuseppe Banfi |
| 33 |
[GO] |
2022―May―07 |
Non-glycosylated SARS-CoV-2 RBD elicited a robust neutralizing antibody response in mice |
Qian Ke, Peng Sun, Tiantian Wang, Taotao Mi, Huifang Xu, Jun Wu, Bo Liu |
| 34 |
[GO] |
2022―Apr―16 |
Detection of SARS-CoV-2 peptide-specific antibodies in Syrian hamster serum by ELISA |
Huy Quang Quach, Inna G. Ovsyannikova, Gregory A. Poland, Richard B. Kennedy |
| 35 |
[GO] |
2022―Mar―15 |
Application of the SARS-CoV-2-S1 ACE-2 receptor interaction as the basis of the fully automated assay to detect neutralizing SARS-CoV-2-S1 antibodies in blood samples |
Daniel Filchtinski, Magnus Sundberg, Heike Berthold, Laura Steller, Kayser José, Sanja Holz, Mario Hinze, Oxana Braeutigam, Johannes Schulte-Pelkum, Raimund Fiedler |
| 36 |
[GO] |
2022―Feb―23 |
The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies |
Shuangzhe Zhang, Chunhui Gao, Tuhin Das, Shuhong Luo, Hao Tang, Xinyi Yao, Chih Yun Cho, Jingquiao Lu, Kino Maravillas, Valerie Jones, Xiaofeng Chen, Ruopan Huang |
| 37 |
[GO] |
2022―Feb―16 |
Clinical and analytical evaluation of the Abbott AdviseDx quantitative SARS-CoV-2 IgG assay and comparison with two other serological tests |
Gabriel N. Maine, Subhashree Mallika Krishnan, Kelly Walewski, Jillian Trueman, Elizabeth Sykes, Qian Sun |
| 38 |
[GO] |
2022―Jan―31 |
Evaluation of circulating leucocyte populations both in subjects with previous SARS-COV-2 infection and in healthy subjects after vaccination |
Vincenzo Grimaldi, Giuditta Benincasa, Giusi Moccia, Annunziata Sansone, Giuseppe Signoriello, Claudio Napoli |
| 39 |
[GO] |
2022―Jan―07 |
A vaccine built from potential immunogenic pieces derived from the SARS-CoV-2 spike glycoprotein: A computational approximation |
Jose Marchan |
| 40 |
[GO] |
2022―Jan―06 |
Role of antinuclear antibodies in COVID-19 patients |
Linda Beenet |
| 41 |
[GO] |
2021―Nov―26 |
Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects |
Alessandro Manenti, Elena Gianchecchi, Francesca Dapporto, Margherita Leonardi, Paolo Cantaloni, Filippo Fattorini, Pietro Piu, Valentina Bollati, Ugo Pastorino, Giovanni Apolone, Gabriella Sozzi, Emanuele Montomoli |
| 42 |
[GO] |
2021―Nov―26 |
Murine monoclonal antibodies against RBD of the SARS-CoV-2 spike protein as useful analytical tools for subunit vaccine development and clinical trials |
Omar R. Blanco, Dayamí Dorta, Carlos A. Hernández, Daymí Abreu, Andy G. Domínguez, Yaramis Luna, Onel Valdivia, Maylín Pérez-Bernal, Celia Tamayo, Gilda Lemos, Ivis Pasarón, Joel J. Pérez, Liudmila Benítez, Mónica Bequet-Romero, Anitza Fraga Quintero, Yeosvany Cabrera, Enrique R. Pérez |
| 43 |
[GO] |
2021―Nov―08 |
Development and evaluation of a low cost IgG ELISA test based in RBD protein for COVID-19 |
Luciana Villafañe, Lucía Gallo Vaulet, Florencia M. Viere, Laura I. Klepp, Marina A. Forrellad, María M. Bigi, María I. Romano, Giovanni Magistrelli, Marcelo Rodríguez Fermepin, Fabiana Bigi |
| 44 |
[GO] |
2021―Oct―30 |
Antinuclear antibodies (ANAs) detected by indirect immunofluorescence (IIF) method in acute COVID-19 infection; future roadmap for laboratory diagnosis |
Bilal Olcay Peker, Aslı Gamze Şener, Figen Kaptan Aydoğmuş |
| 45 |
[GO] |
2021―Oct―11 |
Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection and vaccination |
Pratik Datta, Rahul Ukey, Natalie Bruiners, William Honnen, Mary O. Carayannopoulos, Charles Reichman, Alok Choudhary, Alberta Onyuka, Deborah Handler, Valentina Guerrini, Pankaj K. Mishra, Hannah K. Dewald, Alfred Lardizabal, Leeba Lederer, Aliza L. Leiser, Sabiha Hussain, Sugeet K. Jagpal, Jared Radbel, Tanaya Bhowmick, Daniel B. Horton, Emily S. Barrett, Yingda L. Xie, Patricia Fitzgerald-Bocarsly, Stanley H. Weiss, Melissa Woortman, Heta Parmar, Jason Roy, Maria Gloria Dominguez-Bello, Martin J. Blaser, Jeffrey L. Carson, Reynold A. Panettieri, Steven K. Libutti, Henry F. Raymond, Abraham Pinter, Maria Laura Gennaro |
| 46 |
[GO] |
2021―Sep―30 |
Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samples |
Sasha E. Larsen, Bryan J. Berube, Tiffany Pecor, Evan Cross, Bryan P. Brown, Brittany Williams, Emma Johnson, Pingping Qu, Lauren Carter, Samuel Wrenn, Elizabeth Kepl, Claire Sydeman, Neil P. King, Susan L. Baldwin, Rhea N. Coler |
| 47 |
[GO] |
2021―Sep―28 |
A flow cytometry-based proliferation assay for clinical evaluation of T-cell memory against SARS-CoV-2 |
Sara Lind Enoksson, Peter Bergman, Jonas Klingström, Fredrik Boström, Rui Da Silva Rodrigues, Malin Winerdal, Per Marits |
| 48 |
[GO] |
2021―Jul―22 |
Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma |
Leah Huey, Gillian Andersen, Patricia A. Merkel, Thomas E. Morrison, Mary McCarthy, Melkon G. DomBourian, Kyle Annen, Erica D. Dawson, Kathy L. Rowlen, Vijaya Knight |
| 49 |
[GO] |
2021―Jul―06 |
Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response |
Anura David, Lesley Scott, Sarika Jugwanth, Maemu Gededzha, Trish Kahamba, Nontobeko Zwane, Nakampe Mampeule, Ian Sanne, Wendy Stevens, Elizabeth S. Mayne |
| 50 |
[GO] |
2021―Apr―26 |
SARS-CoV-2 serology testing: Progress and challenges |
Aria C. Shi, Ping Ren |
| 51 |
[GO] |
2021―Mar―27 |
SARS-CoV-2 diagnostics: Towards a more comprehensive approach to routine patient testing |
Clive Carter, Pamela Hughes, Anna McHugh, Fatima Nadat, Penny Lewthwaite, Sinisa Savic, Brendan Clark |
| 52 |
[GO] |
2021―Mar―26 |
Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients |
A.M. Cook, S.E. Faustini, L.J. Williams, A.F. Cunningham, M.T. Drayson, A.M. Shields, D. Kay, L. Taylor, T. Plant, A. Huissoon, G. Wallis, S. Beck, S.E. Jossi, M. Perez-Toledo, M.L. Newby, J.D. Allen, M. Crispin, S. Harding, A.G. Richter |
| 53 |
[GO] |
2021―Mar―24 |
Diagnostic and analytical performance evaluation of ten commercial assays for detecting SARS-CoV-2 humoral immune response |
Marnix Mylemans, Eveline Van Honacker, Louis Nevejan, Stefanie van den Bremt, Laura Hofman, Jeroen Poels, Lien Cattoir, An Boel, Lieve Van Hoovels |
| 54 |
[GO] |
2021―Feb―11 |
Parameters of immunoglobulin extraction from dried blood spot cards and immunoassays for detection of antibody response to pathogens including the novel SARS-CoV-2 |
Ianko Iankov, Kimberly Viker, Coleman Turgeon, Dietrich Matern, Evanthia Galanis |
| 55 |
[GO] |
2021―Jan―07 |
Development and characterization of an indirect ELISA to detect SARS-CoV - 2 spike protein-specific antibodies |
Verena Krähling, Sandro Halwe, Cornelius Rohde, Dirk Becker, Susanne Berghöfer, Christine Dahlke, Markus Eickmann, Meryem S. Ercanoglu, Lutz Gieselmann, Astrid Herwig, Alexandra Kupke, Helena Müller, Petra Neubauer-Rädel, Florian Klein, Christian Keller, Stephan Becker |
| 56 |
[GO] |
2020―Nov―28 |
Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples |
Livia Mazzini, Donata Martinuzzi, Inesa Hyseni, Linda Benincasa, Eleonora Molesti, Elisa Casa, Giulia Lapini, Pietro Piu, Claudia Maria Trombetta, Serena Marchi, Ilaria Razzano, Alessandro Manenti, Emanuele Montomoli |
| 57 |
[GO] |
2020―Nov―07 |
Analytical performance of lateral flow immunoassay for SARS-CoV-2 exposure screening on venous and capillary blood samples |
Margaret A. Black, Guomiao Shen, Xiaojun Feng, Wilfredo F. Garcia Beltran, Yang Feng, Varshini Vasudevaraja, Douglas Allison, Lawrence H. Lin, Tatyana Gindin, Michael Astudillo, Diane Yang, Mandakolathur Murali, A. John Iafrate, George Jour, Paolo Cotzia, Matija Snuderl |
| 58 |
[GO] |
2020―Oct―31 |
SARS-CoV-2 variants lacking a functional ORF8 may reduce accuracy of serological testing |
Filipe Pereira |
| 59 |
[GO] |
2020―Aug―20 |
Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays |
Melkon G. DomBourian, Kyle Annen, Leah Huey, Gillian Andersen, Patricia A. Merkel, Sarah Jung, Samuel R. Dominguez, Vijaya Knight |
| 60 |
[GO] |
2020―Aug―08 |
SARS-CoV-2-specific ELISA development |
Vicky Roy, Stephanie Fischinger, Caroline Atyeo, Matthew Slein, Carolin Loos, Alejandro Balazs, Corinne Luedemann, Michael Gerino Astudillo, Diane Yang, Duane Wesemann, Richelle Charles, A. John Lafrate, Jared Feldman, Blake Hauser, Tim Caradonna, Tyler E. Miller, Mandakolathur R. Murali, Lindsey Baden, Eric Nilles, Edward Ryan, Douglas Lauffenburger, Wilfredo Garcia Beltran, Galit Alter, Galit Alter |
| 61 |
[GO] |
2020―Jun―17 |
Agrodiag PorCoV: A multiplex immunoassay for the differential diagnosis of porcine enteric coronaviruses |
Rémi Malbec, Kay Kimpston-Burkgren, Elisa Vandenkoornhuyse, Christophe Olivier, Vianney Souplet, Christophe A�rt, Jose Antonio Carrillo-Ávila, David Baum, Luis Giménez-Lirola |
|
